Amy Mahery
Vermögen: 5 $ am 30.06.2026
Vermögen: 5 $ am 30.06.2026
Ms. Amy Mahery is an Independent Director at CNS Pharmaceuticals, Inc. She is on the Board of Directors at CNS Pharmaceuticals, Inc. Ms. Mahery was previously employed as a Chief Commercial Officer by Roivant Sciences Ltd. and a Senior Vice President by EMD Serono, Inc. She received her undergraduate degree from Trinity College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.04.2026 | 1 ( 0 % ) | 5 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 18.01.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 01.12.2024 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | 01.07.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Roivant Sciences Ltd.
Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Trinity College
Trinity College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen